title: Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy.
abstract: The inter- and intracellular distribution of the DNA repair protein O6-alkylguanine-DNA alkyltransferase (ATase) may be an important factor in the sensitivity or resistance of tumours to treatment with certain alkylating agents, including the methyltriazenes and nitrosoureas. In order to examine this issue 26 human brain tumour sections (23 high grade gliomas and three low grade gliomas) were examined for ATase expression by immunohistochemistry using a rabbit anti-human ATase polyclonal antibody. Positive staining, seen as fine black granules mainly confined to the nucleus, was observed in all the glioma sections examined. There was marked cellular heterogeneity, ranging from cells completely devoid of staining to cells with very intense staining. Semi-quantitatively, in the 23 high grade gliomas examined six had 1+ staining, seven had 2+ staining and 10 had 3+ staining, whereas all three low grade gliomas had 1+ staining. These results are in contrast to published reports showing that approximately 35% of human brain tumour-derived cell lines and xenografts had very low levels of ATase activity and suggest that the complete lack of ATase is not a common occurrence in high grade glioma.
authors.affiliation: CRC Department of Carcinogenesis, Paterson Institute for Cancer Research, Manchester, UK.
authors.forename: S M
authors.initials: SM
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Reid
authors.forename: R H
authors.initials: RH
authors.lastname: Elder
authors.forename: N
authors.initials: N
authors.lastname: Thatcher
authors.forename: G P
authors.initials: GP
authors.lastname: Margison
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy / Q000201:enzymology*; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D002330:Carmustine / Q000627:therapeutic use*; D005909:Glioblastoma / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D007150:Immunohistochemistry; D008780:Methyltransferases / Q000378:metabolism*; D019853:O(6)-Methylguanine-DNA Methyltransferase
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008780:Methyltransferases; D019853:O(6)-Methylguanine-DNA Methyltransferase; D002330:Carmustine